Each GLP-1 medication has a slightly different profile in terms of duration of action, gastrointestinal effects, and individual response
[DOI] [PubMed] [Google Scholar] 133.Vallianou N.G., Dalamaga M., Pavlou A., Rebelos E., Karamanolis N.N., Papachristoforou E., Mavrothalassitis E., Eleftheriadou I., Tentolouris N., Kounatidis D
August 2025: A growing body of scientific research says that Mounjaro and other GLP-1 drugs may lead to dangerous side effects that affect vision
To date, no clear clinical evidence has suggested a tumorigenic effect of GLP-1 RAs [24-26], yet the steadily increasing use of these agents worldwide emphasizes the importance of thoroughly evaluating their potential association with cancer risk